BERNARDES, EMERSONCARAVAN, PETERDAM, R.M. vanDEUTHER-CONRAD, WINNIEELLIS, BEVERLEYFURUMOTO, SHOZOGUILLET, BENJAMINHUANG, YA-YAOJIA, HONGMEILAVERMAN, PETERLI, ZIJINGLIU, ZHAOFEILODI, FILIPPOMIAO, YUBINPERK, LARSSCHIRRMACHER, RALFVERCOULLIE, JOHNNYYANG, HUAYANG, MINYANG, XINGZHANG, JUNBOZHANG, MING-RONGZHU, HUA2022-08-032022-08-032022BERNARDES, EMERSON; CARAVAN, PETER; DAM, R.M. van; DEUTHER-CONRAD, WINNIE; ELLIS, BEVERLEY; FURUMOTO, SHOZO; GUILLET, BENJAMIN; HUANG, YA-YAO; JIA, HONGMEI; LAVERMAN, PETER; LI, ZIJING; LIU, ZHAOFEI; LODI, FILIPPO; MIAO, YUBIN; PERK, LARS; SCHIRRMACHER, RALF; VERCOULLIE, JOHNNY; YANG, HUA; YANG, MIN; YANG, XING; ZHANG, JUNBO; ZHANG, MING-RONG; ZHU, HUA. Highlight selection of radiochemistry and radiopharmacy developments by editorial board. <b>EJNMMI Radiopharmacy and Chemistry</b>, v. 7, n. 1, p. 1-17, 2022. DOI: <a href="https://dx.doi.org/10.1186/s41181-022-00162-3">10.1186/s41181-022-00162-3</a>. Disponível em: http://repositorio.ipen.br/handle/123456789/33168.2365-421Xhttp://repositorio.ipen.br/handle/123456789/33168Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included. Conclusion: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.1-17openAccessradiopharmaceuticalsradiochemistryantigensreceptorsimidazolesnitro compoundsArtigo de periódico1710.1186/s41181-022-00162-30000-0002-0029-7313https://orcid.org/0000-0002-0029-7313Sem Percentil84.25